Type of disease

Clinically isolated syndrome

Relapsing remitting

Primary progressive

Secondary progressive

1 (9.1%)

7 (63.6%)

1 (9.1%)

2 (18.2%)

Treatment

None

IFN-β

Glatiramer acetate

4 (36.4%)

6 (54.5%)

1 (9.1%)